BioLife Solutions Inc (BLFS) News
Follow BioLife Solutions Inc (BLFS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index surging over 250 points on Tuesday. Shares of Apogee Enterprises Inc (NASDAQ: APOG ) rose sharply after the company announced better-than-expected second-quarter financia
LIVE | Oct 06, 2026, 02:20 PM UTC
M
Repligen to acquire BioLife Solutions for $11.25 cash plus stock
BioLife Solutions agreed to be acquired by Repligen for $11.25 cash and 0.1442 shares of Repligen stock per BioLife share.
MNA | Sep 09, 2026, 09:24 PM UTC
L
BLFS Downgrade from Overweight to Equal Weight at Stephens
BLFS Downgrade from Overweight to Equal Weight at Stephens
EQUITY | Jul 27, 2026, 12:07 PM UTC
L
BLFS Downgrade from Buy to Hold W/$31.00 PT (from $33.00) at TD Cowen
BLFS Downgrade from Buy to Hold W/$31.00 PT (from $33.00) at TD Cowen
EQUITY | Jul 23, 2026, 11:55 AM UTC
L
BLFS downgraded from Buy to Hold W/ $21 PT (from $33) @ TDCowen
BLFS downgraded from Buy to Hold W/ $21 PT (from $33) @ TDCowen
EQUITY | Jul 23, 2026, 10:53 AM UTC
L
RGEN said it would buy Biolife Solutions (BLFS) in a cash-and-stock deal valued at about $1.5B, to expand its presence in the fast-growing c
RGEN said it would buy Biolife Solutions (BLFS) in a cash-and-stock deal valued at about $1.5B, to expand its presence in the fast-growing cell therapy market; Biolife shareholders will receive $11.25 in cash and 0.1442
EQUITY | Jul 22, 2026, 10:19 AM UTC